Cargando…

Non-Invasive Assessment of Endothelial Dysfunction in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is characterised by an increased pressure in the pulmonary arterial circulation, resulting in the elevation of pulmonary vascular resistance. Pulmonary endothelial dysfunction and inflammation, triggered by shear stress and hypoxia, constitute the hallmarks of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dara, Athanasia, Arvanitaki, Alexandra, Theodorakopoulou, Marieta, Athanasiou, Christos, Pagkopoulou, Eleni, Boutou, Afroditi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314877/ https://www.ncbi.nlm.nih.gov/pubmed/34386697 http://dx.doi.org/10.31138/mjr.32.1.6

Ejemplares similares

Nailfold Capillaroscopy in Systemic Sclerosis Patients with and without Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Minopoulou, Ioanna, et al.
Publicado: (2021)

Endothelial dysfunction in COPD: a systematic review and meta-analysis of studies using different functional assessment methods
por: Theodorakopoulou, Marieta P., et al.
Publicado: (2021)

Peripheral microangiopathy in precapillary pulmonary hypertension: a nailfold video capillaroscopy prospective study
por: Arvanitaki, Alexandra, et al.
Publicado: (2021)

Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease
por: Theodorakopoulou, Marieta P, et al.
Publicado: (2021)

The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2022)

Study of Peripheral Microcirculation Assessed by Nailfold Video-Capillaroscopy and Association with Markers of Endothelial Dysfunction and Inflammation in Rheumatoid Arthritis
por: Angeloudi, Elena, et al.
Publicado: (2022)

Long COVID-19 Pulmonary Sequelae and Management Considerations
por: Boutou, Afroditi K., et al.
Publicado: (2021)

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
por: Hudson, Jaylen, et al.
Publicado: (2021)

Nailfold Videocapillaroscopy for the Evaluation of Peripheral Microangiopathy in Rheumatoid Arthritis
por: Anyfanti, Panagiota, et al.
Publicado: (2022)

Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management
por: Baroutidou, Amalia, et al.
Publicado: (2022)

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Right Heart Catheterization in Pediatric Pulmonary Arterial Hypertension: Insights and Outcome from a Large Tertiary Center
por: Xu, Zhuoyuan, et al.
Publicado: (2022)

Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction
por: Vrigkou, Eleni, et al.
Publicado: (2020)

Pulmonary Arterial Hypertension and Endothelial Dysfunction Is Linked to NADPH Oxidase-Derived Superoxide Formation in Venous Thrombosis and Pulmonary Embolism in Mice
por: Brandt, Moritz, et al.
Publicado: (2018)

Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
por: Kurakula, Kondababu, et al.
Publicado: (2021)

Anesthesia for minimally invasive cardiac surgery: is it still a place for opioids?
por: Sarridou, Despoina G., et al.
Publicado: (2021)

Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
por: Ranchoux, Benoît, et al.
Publicado: (2017)

S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension
por: Ban, Yiqian, et al.
Publicado: (2019)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

Mitochondrial dysfunction in pulmonary arterial hypertension
por: Zhang, Weiwei, et al.
Publicado: (2022)

Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2019)

Chronic Thromboembolic Pulmonary Hypertension: Do not Miss the Chance for an Early Diagnosis
por: Bagalas, Vasilis, et al.
Publicado: (2014)

Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?
por: Papagiouvanni, Ioanna, et al.
Publicado: (2022)

Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension
por: Chibana, Hidetoshi, et al.
Publicado: (2017)

Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension in Greece: Data from the Hellenic Pulmonary Hypertension Registry
por: Karyofyllis, Panagiotis, et al.
Publicado: (2022)

Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

Endothelial dysfunction as a factor leading to arterial hypertension
por: Drożdż, Dorota, et al.
Publicado: (2022)

Endothelial dysfunction in pulmonary arterial hypertension: loss of cilia length regulation upon cytokine stimulation
por: Dummer, Anneloes, et al.
Publicado: (2018)

BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series)
por: Frump, Andrea, et al.
Publicado: (2018)

Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension
por: Egnatchik, Robert A., et al.
Publicado: (2017)

Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension
por: Simmons Beck, Robert, et al.
Publicado: (2023)

Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Kidney dysfunction in patients with pulmonary arterial hypertension
por: Nickel, N.P., et al.
Publicado: (2017)

Pulmonary Vascular Platform Models the Effects of Flow and Pressure on Endothelial Dysfunction in BMPR2 Associated Pulmonary Arterial Hypertension
por: D’Amico, Reid W., et al.
Publicado: (2018)

PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Ali, Md Khadem, et al.
Publicado: (2023)

Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
por: Smolders, V. F. E. D., et al.
Publicado: (2022)

Peripheral Microangiopathy in Patients with Precapillary Pulmonary Hypertension: Correlation with Cardiac Function and Patients’ Functional Capacity. Study Design and Rationale
por: Arvanitaki, Alexandra, et al.
Publicado: (2020)

The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis: A Case Control Study
por: Manika, Katerina, et al.
Publicado: (2012)

Endothelial Dysfunction in Experimental Models of Arterial Hypertension: Cause or Consequence?
por: Bernatova, Iveta
Publicado: (2014)

Effects of Caloric Restriction Diet on Arterial Hypertension and Endothelial Dysfunction
por: Di Daniele, Nicola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g659akhkfd5fs4qrp2rb5nns72